What makes some cancers more deadly?

April 23, 2014, Flinders University
What makes some cancers more deadly?
Dr Lauren Thurgood is investigating what makes a common form of leukaemia more deadly.

A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months.

Dr Lauren Thurgood, based in the Department of Haematology and Genetic Pathology, is studying a common form of leukaemia called (CLL) to better understand why a sub-group of patients with this particular type of cancer respond poorly to treatment.

Comprising about 30 per cent of all leukaemias, CLL is a slow-growing form of the disease in which the bone marrow makes too many .

"I'm looking at proteins in the cancer cells to try to work out why some patients have a more pathogenic disease while other people who have CLL live longer and don't have any problems," Dr Thurgood said.

"We know from previous research that people with a poor prognosis have a that makes them have a more aggressive disease but we still need to understand at a cellular level what that gene defect does to the cells," she said.

"The cancer cells basically talk to surrounding cells in the so we want to know how they interact with the and how they're told to stay alive.

"Once we know how the cells communicate, we could look at developing a targeted drug therapy to stop the interaction, which would essentially prevent the from taking over."

With CLL typically diagnosed in older adults, Dr Thurgood said the disease was set to become more prevalent as the population ages.

"The fact we're living longer means the frequency of the disease is going to skyrocket because a lot more people will be diagnosed with it, therefore any new information will become crucial to prevention and treatment.

"Once we've refined our research methods and we know more about CLL we can apply our knowledge to other leukaemias, including the pathogenic childhood cancers."

Explore further: New potential treatment opportunities for leukemia patients

Related Stories

New potential treatment opportunities for leukemia patients

April 14, 2014
(Medical Xpress)—The long-term survival of people suffering from chronic lymphocytic leukemia (CLL) could be increased with the development of new therapeutic strategies.

Researchers develop new approach to chronic lymphocytic leukemia treatment

March 14, 2014
Dartmouth researchers have developed a novel and unique approach to treating Chronic Lymphocytic Leukemia (CLL), a form of blood cancer that often requires repeated chemotherapy treatments to which it grows resistant. The ...

Boosting immune responses against leukaemia

November 21, 2012
(Medical Xpress)—In the first of its kind, a translational study undertaken at the Malaghan Institute of Medical Research has revealed that boosting the activity of a rare type of immune cell could be an effective way to ...

People with leukaemia are more prone to infection – but not from one particular herpes virus

March 19, 2014
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...

Leap in leukemia treatment reported by Dartmouth researchers

May 13, 2013
Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, ...

Monoclonal antibody targets, kills leukemia cells

March 25, 2013
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.